SHERYL WILSON: Open Payments
NPI 1285957647 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 52 payments from 18 companies in 2025. Trend: 2023 $1,848 · 2024 $1,394 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $196 |
| Regeneron Healthcare Solutions, Inc. | 5 | $144 |
| Novartis Pharmaceuticals Corporation | 4 | $115 |
| Janssen Biotech, Inc. | 5 | $101 |
| Amgen Inc. | 3 | $72 |
| Galderma Laboratories, L.P. | 4 | $66 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $47 |
| MERZ NORTH AMERICA, INC. | 1 | $44 |
| ConvaTec Inc. | 2 | $39 |
| UCB, Inc. | 1 | $39 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, OTEZLA, COSENTYX, Xeomin, INNOVAMATRIX AC, Bimzelx.
Industry payments across FL — which companies pay providers there.
